286: Coagulation defects
286.5 Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
286.52: Acquired hemophilia
Autoimmune hemophilia
Autoimmune inhibitors to clotting factors
Secondary hemophilia
286.53: Antiphospholipid antibody with hemorrhagic disorder
Lupus anticoagulant (LAC) with hemorrhagic disorder
Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
Excludes:
antiphospholipid antibody, finding without diagnosis (795.79)
antiphospholipid antibody syndrome (289.81)
antiphospholipid antibody with hypercoagulable state (289.81)
lupus anticoagulant (LAC) finding without diagnosis (795.79)
lupus anticoagulant (LAC) with hypercoagulable state (289.81)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (795.79)
systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (289.81)
286.59: Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Antithrombinemia
Antithromboplastinemia
Antithromboplastinogenemia
Increase in:
anti-II (prothrombin)
anti-VIIIa
anti-IXa
anti-Xla

Home